BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22160026)

  • 1. How I diagnose and manage HIT.
    Warkentin TE
    Hematology Am Soc Hematol Educ Program; 2011; 2011():143-9. PubMed ID: 22160026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The approach to heparin-induced thrombocytopenia.
    Linkins LA; Warkentin TE
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.
    Krauel K; Fürll B; Warkentin TE; Weitschies W; Kohlmann T; Sheppard JI; Greinacher A
    J Thromb Haemost; 2008 Dec; 6(12):2160-7. PubMed ID: 18983520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
    Lo GK; Sigouin CS; Warkentin TE
    Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
    Warkentin TE
    Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HITlights: a career perspective on heparin-induced thrombocytopenia.
    Warkentin TE
    Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of heparin-induced thrombocytopenia.
    Spinler SA; Dager W
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S5-11. PubMed ID: 14593977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin-induced thrombocytopenia: recent data].
    Gruel Y; Rollin J; Leroux D; Pouplard C
    Rev Med Interne; 2014 Mar; 35(3):174-82. PubMed ID: 24074968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin induced thrombocytopenia.
    Gupta S; Gupta MM
    J Assoc Physicians India; 2008 Aug; 56():622-7. PubMed ID: 19051709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of heparin-induced thrombocytopenia].
    Aouizerate P; Guizard M
    Therapie; 2002; 57(6):577-88. PubMed ID: 12666266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
    Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia.
    Althaus K; Hron G; Strobel U; Abbate R; Rogolino A; Davidson S; Greinacher A; Bakchoul T
    Thromb Res; 2013 Mar; 131(3):e85-90. PubMed ID: 23351665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
    Krauel K; Hackbarth C; Fürll B; Greinacher A
    Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on evidence based diagnostic and confirmatory testing strategies for heparin induced thrombocytopenia using combined immunological and functional assays.
    Amiral J; Seghatchian J
    Transfus Apher Sci; 2018 Dec; 57(6):804-811. PubMed ID: 30401517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for heparin-induced thrombocytopenia antibodies.
    Warkentin TE; Sheppard JA
    Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia: natural history, diagnosis, and management.
    Deitcher SR; Carman TL
    Vasc Med; 2001; 6(2):113-9. PubMed ID: 11530963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three different immunoassays in the diagnosis of heparin-induced thrombocytopenia.
    Vianello F; Sambado L; Scarparo P; Lombardi A; Bernardi D; Plebani M; Fabris F
    Clin Chem Lab Med; 2015 Feb; 53(2):257-63. PubMed ID: 25324455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of heparin-induced thrombocytopenia (HIT) based on its atypical immunological features].
    Miyata S; Maeda T
    Rinsho Ketsueki; 2016 Mar; 57(3):322-32. PubMed ID: 27076245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.